CancerFax

Mobile phone radiation and brain tumors

Sai SreeWritten by Sai SreeMedically ReviewedUpdated June 5, 20203 min read
Mobile phone radiation and brain tumors
In this article
  1. California Department of Public Health (CDPH) Cell Phone Safety Guidelines
  2. 2026 Federal Policy Shift: The HHS New Study
  3. How CancerFax Helps

California Department of Public Health (CDPH) Cell Phone Safety Guidelines

The California Department of Public Health issued guidelines on cell phone radiation and how to reduce exposure.

According to the CBS report, although there is no conclusive medical evidence, some studies have shown that mobile phone use may be related to brain tumors , headaches, low sperm count, memory, hearing and sleep problems.

Dr. Smith of the California Department of Public Health told CBS, “A lot of people are worried that high-frequency use of mobile phones is harmful to health and whether it is safe to use mobile phones.”

Dr. Smith said that when you sleep, your phone is at least one arm away from your body. Also, don’t put your phone in your pocket, put it in your wallet, or carry it with you.

2026 Federal Policy Shift: The HHS New Study

The new guide also recommends: reduce the use of mobile phones when the signal is weak; use less mobile phones to transmit audio or video, download or upload large files; do not put the mobile phone on the bed at night; take off the headset without making a call.

However, despite the release of new guidelines, the government did not say that mobile phones are dangerous.

Dr. Smith stated that our position is that science is constantly evolving.

According to a CBS News report, the main reason for national officials to publish this guideline is that new data shows that cell phone usage has reached its highest level in history, with 95% of Americans using cell phones.

The International Agency for Research on Cancer of the World Health Organization has classified the radiation emitted by mobile phones as “probably carcinogenic.

The results of some studies published last year by the National Toxicology Program of the United States show that radio frequency radiation poses a higher risk of two types of cancer in male rats. More importantly, this study found that the higher the radiation dose, the stronger the response.

How CancerFax Helps

CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.

description
Medical Record Review

We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.

verified_user
Eligibility Coordination

We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.

hub
Hospital Communication

We support appointment coordination, document submission, translation, and direct communication with international departments.

flight
Travel & Admission Support

For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.

explore
Treatment & Trial Navigation

If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.

support_agent
End-to-end Coordination

From inquiry through to follow-up, our coordinators provide a single point of contact for the family.

CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.

Sai Sree

About Sai Sree

✓ Reviewed for medical accuracy by the CancerFax review panel.

Medical Disclaimer

This article is for educational purposes only and should not replace medical advice, diagnosis, or treatment from a qualified oncology specialist. Every patient's case is different. Treatment decisions should always be made after a review of complete medical records by the treating medical team.

Treatment availability, eligibility, timelines, and access can change. Any clinical trial participation depends on detailed review and approval by the trial hospital or investigator.